Uscom Limited (ASX:UCM)
Australia
· Delayed Price · Currency is AUD 0.0120
+0.0010 (9.09%)
At close: Sep 23, 2025
Uscom Revenue
Uscom had revenue of 693.51K AUD in the half year ending December 31, 2025, a decrease of -64.53%. This brings the company's revenue in the last twelve months to 2.41M, down -8.34% year-over-year. In the fiscal year ending June 30, 2025, Uscom had annual revenue of 2.58M, down -30.80%.
Revenue (ttm)
2.41M
Revenue Growth
-8.34%
P/S Ratio
1.29
Revenue / Employee
68.92K
Employees
35
Market Cap
3.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.58M | -1.15M | -30.80% |
| Jun 30, 2024 | 3.73M | 1.06M | 39.89% |
| Jun 30, 2023 | 2.66M | 154.48K | 6.16% |
| Jun 30, 2022 | 2.51M | -1.35M | -34.95% |
| Jun 30, 2021 | 3.86M | -426.65K | -9.96% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adherium | 1.12M |
| OncoSil Medical | 3.72M |
| Memphasys | 213.98K |
| CONNEQT Health | 5.80M |
| Control Bionics | 6.07M |
| CurveBeam AI | 12.15M |
| Atomo Diagnostics | 3.92M |
| ImpediMed | 14.23M |